Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.
Nusano has raised $115.0M in total funding. The most recent round was Series C. The last funding was announced in October 2024.
Nusano's investors include S32, Wasatch Group.
Nusano is headquartered in Valencia, United States.
Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.
Nusano is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nusano — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/nusano. Accessed August 1, 2026.
VCBacked. (2024). Nusano — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/nusano
{{cite web |title=Nusano — Funding & Investors |url=https://www.vcbacked.co/company/nusano |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated